Regenxbio Inc. (RGNX) PT Lowered to $10 at Goldman Sachs

May 15, 2026 4:56 AM

Goldman Sachs analyst Paul Choi lowered the price target on Regenxbio Inc. (NASDAQ: RGNX) to $10.00 (from $12.00) while maintaining ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found